Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Burgundy Asset Management Dumps Gladstone Investment Corporation (GAIN) Shares

Burgundy Asset Management Ltd. has decreased its exposure to Gladstone Investment Corporation (NASDAQ:GAIN). In a recent filing with the Securities and Exchange Commission, the fund revealed the reduction of its stake to 483,106 shares from 2.65 million shares reported in its latest 13F filing. Burgundy’s current position accounts for approximately 1.82% of the company’s common stock.

Gladstone Investment (GAIN)

John Overdeck and David Siegel, the managers of Two Sigma Advisors, are on the other hand bullish on this stock. According to Two Sigma Advisors’ latest 13F report, the fund holds 97,621 shares, a quarterly increase of 7%, valued at $687,000. During the third quarter of 2013, D. E. Shaw opened a position in Gladstone Investment Corporation (NASDAQ:GAIN). His fund, D E Shaw reported ownership of 14,553 shares worth approximately $103 thousand. Cliff Asness is also keeping tabs on this stock as his fund, AQR Capital Management, holds 13,320 valued at about $94 thousand.

Gladstone Investment Corporation (NASDAQ:GAIN) is a business development company. With a current share price of $7.54, the company has a market cap of $199.6 million. The stock has a beta of 0.71 and pays a quarterly dividend of 0.06, which represents a yield of 9.55%. Gladstone has a Price to Earnings (P/E) ratio of 13.54.

For the three months ended September 30, 2013, Gladstone Investment reported revenues of $11.3 million and earnings per share (EPS) of $0.24. For the current quarter, analysts expect the company to register revenues of $8.62 million and earnings of $0.17 per share. On November 29th, shareholders were awarded a one-time bonus dividend of $0.05 per share.

Disclosure: none

Recommended reading:

Potomac Capital Partners Opens Position in Meru Networks, Inc. (MERU)

Bison Capital Holding Opens Position In AirMedia Group Inc (ADR) (AMCN)

Roumell Asset Management Nominates Candidates for Transcept Pharmaceuticals Inc (TSPT)’s Board

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!